These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37558679)

  • 1. SRSF3/AMOTL1 splicing axis promotes the tumorigenesis of nasopharyngeal carcinoma through regulating the nucleus translocation of YAP1.
    Xu XC; Jiang JX; Zhou YQ; He S; Liu Y; Li YQ; Wei PP; Bei JX; Sun J; Luo CL
    Cell Death Dis; 2023 Aug; 14(8):511. PubMed ID: 37558679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes.
    Song X; Wan X; Huang T; Zeng C; Sastry N; Wu B; James CD; Horbinski C; Nakano I; Zhang W; Hu B; Cheng SY
    Cancer Res; 2019 Oct; 79(20):5288-5301. PubMed ID: 31462429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic splicing factor SRSF3 regulates ILF3 alternative splicing to promote cancer cell proliferation and transformation.
    Jia R; Ajiro M; Yu L; McCoy P; Zheng ZM
    RNA; 2019 May; 25(5):630-644. PubMed ID: 30796096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inclusion of hnRNP L Alternative Exon 7 Is Associated with Good Prognosis and Inhibited by Oncogene SRSF3 in Head and Neck Squamous Cell Carcinoma.
    Xu L; Shen J; Jia J; Jia R
    Biomed Res Int; 2019; 2019():9612425. PubMed ID: 31828152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splicing factor derived circular RNA circCAMSAP1 accelerates nasopharyngeal carcinoma tumorigenesis via a SERPINH1/c-Myc positive feedback loop.
    Wang Y; Yan Q; Mo Y; Liu Y; Wang Y; Zhang S; Guo C; Wang F; Li G; Zeng Z; Xiong W
    Mol Cancer; 2022 Feb; 21(1):62. PubMed ID: 35227262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splicing factor SRSF3 promotes the progression of cervical cancer through regulating DDX5.
    Che Y; Bai M; Lu K; Fu L
    Mol Carcinog; 2023 Feb; 62(2):210-223. PubMed ID: 36282044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SRSF5 functions as a novel oncogenic splicing factor and is upregulated by oncogene SRSF3 in oral squamous cell carcinoma.
    Yang S; Jia R; Bian Z
    Biochim Biophys Acta Mol Cell Res; 2018 Sep; 1865(9):1161-1172. PubMed ID: 29857020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RBFOX2/GOLIM4 Splicing Axis Activates Vesicular Transport Pathway to Promote Nasopharyngeal Carcinogenesis.
    Luo CL; Xu XC; Liu CJ; He S; Chen JR; Feng YC; Liu SQ; Peng W; Zhou YQ; Liu YX; Wei PP; Li B; Mai HQ; Xia XJ; Bei JX
    Adv Sci (Weinh); 2021 Aug; 8(16):e2004852. PubMed ID: 34180133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SRSF3-Mediated Ki67 Exon 7-Inclusion Promotes Head and Neck Squamous Cell Carcinoma Progression via Repressing AKR1C2.
    Liu M; Lin C; Huang Q; Jia J; Guo J; Jia R
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence.
    Tang Y; Horikawa I; Ajiro M; Robles AI; Fujita K; Mondal AM; Stauffer JK; Zheng ZM; Harris CC
    Oncogene; 2013 May; 32(22):2792-8. PubMed ID: 22777358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic SRSF3 in health and diseases.
    Jia R; Zheng ZM
    Int J Biol Sci; 2023; 19(10):3057-3076. PubMed ID: 37416784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPM1G promotes the progression of hepatocellular carcinoma via phosphorylation regulation of alternative splicing protein SRSF3.
    Chen D; Zhao Z; Chen L; Li Q; Zou J; Liu S
    Cell Death Dis; 2021 Jul; 12(8):722. PubMed ID: 34290239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMOTL1 enhances YAP1 stability and promotes YAP1-driven gastric oncogenesis.
    Zhou Y; Zhang J; Li H; Huang T; Wong CC; Wu F; Wu M; Weng N; Liu L; Cheng ASL; Yu J; Wong N; Lo KW; Tang PMK; Kang W; To KF
    Oncogene; 2020 May; 39(22):4375-4389. PubMed ID: 32313226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of TDP43 inhibits progression of triple-negative breast cancer in coordination with SRSF3.
    Ke H; Zhao L; Zhang H; Feng X; Xu H; Hao J; Wang S; Yang Q; Zou L; Su X; Wang L; Wu C; Wang Y; Nie J; Jiao B
    Proc Natl Acad Sci U S A; 2018 Apr; 115(15):E3426-E3435. PubMed ID: 29581274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splicing machinery dysregulation drives glioblastoma development/aggressiveness: oncogenic role of SRSF3.
    Fuentes-Fayos AC; Vázquez-Borrego MC; Jiménez-Vacas JM; Bejarano L; Pedraza-Arévalo S; L-López F; Blanco-Acevedo C; Sánchez-Sánchez R; Reyes O; Ventura S; Solivera J; Breunig JJ; Blasco MA; Gahete MD; Castaño JP; Luque RM
    Brain; 2020 Dec; 143(11):3273-3293. PubMed ID: 33141183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-1908-5p contributes to the oncogenic function of the splicing factor SRSF3.
    Kim HR; Shin CH; Lee H; Choi KH; Nam DH; Ohn T; Kim HH
    Oncotarget; 2017 Jan; 8(5):8342-8355. PubMed ID: 28039456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serine/Arginine-Rich Splicing Factor 3 Modulates the Alternative Splicing of Cytoplasmic Polyadenylation Element Binding Protein 2.
    DeLigio JT; Stevens SC; Nazario-Muñoz GS; MacKnight HP; Doe KK; Chalfant CE; Park MA
    Mol Cancer Res; 2019 Sep; 17(9):1920-1930. PubMed ID: 31138601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SRSF3-MBNL1-Acin1 circuit constitutes an emerging axis to lessen DNA fragmentation in colorectal cancer via an alternative splicing mechanism.
    Chen YS; Liu CW; Lin YC; Tsai CY; Yang CH; Lin JC
    Neoplasia; 2020 Dec; 22(12):702-713. PubMed ID: 33142236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SRSF3 and hnRNP H1 regulate a splicing hotspot of HER2 in breast cancer cells.
    Gautrey H; Jackson C; Dittrich AL; Browell D; Lennard T; Tyson-Capper A
    RNA Biol; 2015; 12(10):1139-51. PubMed ID: 26367347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of SRSF3 by antisense oligonucleotides sensitizes oral squamous cell carcinoma and breast cancer cells to paclitaxel treatment.
    Sun Y; Yan L; Guo J; Shao J; Jia R
    Cancer Chemother Pharmacol; 2019 Nov; 84(5):1133-1143. PubMed ID: 31515668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.